This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: Yingxu Peng: Innovator in Pharmaceutical Compositions
Introduction
Yingxu Peng is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions containing rosuvastatin calcium. With a total of 2 patents, his work has the potential to impact the medical community positively.
Latest Patents
Yingxu Peng's latest patents include a pharmaceutical composition of rosuvastatin calcium. This invention relates to pharmaceutical compositions containing rosuvastatin calcium of formula (I) and processes for their manufacture. His innovative approach aims to enhance the efficacy and safety of this important medication.
Career Highlights
Currently, Yingxu Peng is associated with AstraZeneca U.K. Limited, where he continues to advance his research and development efforts. His work at this prominent pharmaceutical company allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in medicine.
Collaborations
Some of his coworkers include Sanjeev Hukmichand Kothari and Joseph Richard Creekmore. Their collective expertise fosters an environment of innovation and progress within the company.
Conclusion
Yingxu Peng's contributions to pharmaceutical compositions demonstrate his commitment to improving healthcare through innovation. His work not only reflects his expertise but also highlights the importance of collaboration in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile